BioInsights
Resources for healthcare investors
The Piper Sandler BioInsights research platform provides in-depth analyses across a diverse range of innovative and emerging therapeutic modalities, novel drug targets and disease states, through monthly thematic reports, expert events, catalyst calendars and more.
53
Thematic reports since 2019
201
Companies profiled since 2023
37+
Topics covered since 2019
Market-Driven, Actionable Insights
Piper Sandler’s thematic BioInsights reports dive deep into a diverse array of disease pathways, indications of interest and novel therapeutic modalities. The reports explore current and emerging competitive landscapes and provide detailed profiles of key public and private players in each space – reviewing relevant pipeline and marketed assets, available clinical data and upcoming catalysts of interest.
Emerging themes
Artificial intelligence and machine learning, the evolution of generics and biosimilars
Innovative therapeutic modalities and targets
Cell and gene therapies, gene editing, RNA medicines, radiopharmaceuticals, antibody-drug conjugates, protein degradation, TGF-beta, drugging transcription factors, precision oncology
Novel strategies to address disease indications
Obesity, muscle diseases, autoimmune diseases, epilepsy, chronic hepatitis B, movement disorders, respiratory diseases, women’s and men’s health, cardiovascular diseases
Catalyst Calendars
Our catalyst calendars include summaries of key biopharma events within the Piper Sandler coverage universe.
Key Opinion Leader Day Recaps
Key Opinion Leader day recaps provide detailed thoughts from panel discussions and key takeaways from industry leaders.
Conferences & Events
We bring together key industry executives and our own professionals to provide multiple perspectives, investigate critical trends, and identify the leaders in biopharma.
Insights
Conferences & Events
Biopharma Ski Summit
Spring Biopharma
Heartland Summit
Data as of December 2024.